Browsing Tag
CoSara Diagnostics
3 posts
Co-Diagnostics (Nasdaq: CODX) launches clinical trial for multiplex respiratory test as FDA approval push begins
Co-Diagnostics launches trial for flu, COVID-19, RSV test kit targeting FDA clearance. Learn how it plans to lead in decentralized respiratory diagnostics.
Co-Diagnostics revamps COVID-19 test for FDA clearance amid stability concerns
Co-Diagnostics, Inc. has announced that it is withdrawing its 510(k) clearance application for its Co-Dx PCR COVID-19 test…
CoSara Diagnostics gains CDSCO approval for Saragene COVID-19 2-gene multiplex RT-PCR test
CoSara Diagnostics, a prominent player in the field of molecular diagnostics, has achieved a significant milestone with the…